Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.

Jansweijer JA, Nieuwhof K, Russo F, Hoorntje ET, Jongbloed JD, Lekanne Deprez RH, Postma AV, Bronk M, van Rijsingen IA, de Haij S, Biagini E, van Haelst PL, van Wijngaarden J, van den Berg MP, Wilde AA, Mannens MM, de Boer RA, van Spaendonck-Zwarts KY, van Tintelen JP, Pinto YM.

Eur J Heart Fail. 2017 Apr;19(4):512-521. doi: 10.1002/ejhf.673. Epub 2016 Nov 3.

2.

Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice.

Boross P, Jansen JH, van Tetering G, Nederend M, Brandsma A, Meyer S, Torfs E, van den Ham HJ, Meulenbroek L, de Haij S, Leusen JH.

Immunol Lett. 2014 Aug;160(2):151-7. doi: 10.1016/j.imlet.2014.02.005. Epub 2014 Mar 5.

PMID:
24613852
3.

HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate design.

de Goeij BE, Peipp M, de Haij S, van den Brink EN, Kellner C, Riedl T, de Jong R, Vink T, Strumane K, Bleeker WK, Parren PW.

MAbs. 2014 Mar-Apr;6(2):392-402. doi: 10.4161/mabs.27705. Epub 2014 Jan 3.

4.

Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience.

Hofman N, Tan HL, Alders M, Kolder I, de Haij S, Mannens MM, Lombardi MP, Dit Deprez RH, van Langen I, Wilde AA.

Circulation. 2013 Oct 1;128(14):1513-21. doi: 10.1161/CIRCULATIONAHA.112.000091. Epub 2013 Aug 20.

PMID:
23963746
5.

Ebstein anomaly associated with left ventricular noncompaction: an autosomal dominant condition that can be caused by mutations in MYH7.

Vermeer AM, van Engelen K, Postma AV, Baars MJ, Christiaans I, De Haij S, Klaassen S, Mulder BJ, Keavney B.

Am J Med Genet C Semin Med Genet. 2013 Aug;163C(3):178-84. doi: 10.1002/ajmg.c.31365. Epub 2013 Jun 21. Review.

PMID:
23794396
6.

The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden.

Boross P, Jansen JH, de Haij S, Beurskens FJ, van der Poel CE, Bevaart L, Nederend M, Golay J, van de Winkel JG, Parren PW, Leusen JH.

Haematologica. 2011 Dec;96(12):1822-30. doi: 10.3324/haematol.2011.047159. Epub 2011 Aug 31.

7.

c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of FcalphaRI and FcRgamma-chain.

Bakema JE, Hiemstra IH, Bakker J, de Haij S, Kok Y, Adema G, van Egmond M, Coffer PJ, van de Winkel JG, Leusen JH.

Eur J Immunol. 2010 Jul;40(7):2035-40. doi: 10.1002/eji.200939985.

8.

In vivo cytotoxicity of type I CD20 antibodies critically depends on Fc receptor ITAM signaling.

de Haij S, Jansen JH, Boross P, Beurskens FJ, Bakema JE, Bos DL, Martens A, Verbeek JS, Parren PW, van de Winkel JG, Leusen JH.

Cancer Res. 2010 Apr 15;70(8):3209-17. doi: 10.1158/0008-5472.CAN-09-4109. Epub 2010 Mar 30.

9.

Inside-out regulation of Fc alpha RI (CD89) depends on PP2A.

Bakema JE, Bakker A, de Haij S, Honing H, Bracke M, Koenderman L, Vidarsson G, van de Winkel JG, Leusen JH.

J Immunol. 2008 Sep 15;181(6):4080-8.

10.

A hydrogen-bonding network in mammalian sorbitol dehydrogenase stabilizes the tetrameric state and is essential for the catalytic power.

Hellgren M, Kaiser C, de Haij S, Norberg A, Höög JO.

Cell Mol Life Sci. 2007 Dec;64(23):3129-38.

PMID:
17952367
11.

Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.

Bakema JE, de Haij S, den Hartog-Jager CF, Bakker J, Vidarsson G, van Egmond M, van de Winkel JG, Leusen JH.

J Immunol. 2006 Mar 15;176(6):3603-10.

12.

Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1.

de Haij S, Woltman AM, Trouw LA, Bakker AC, Kamerling SW, van der Kooij SW, Chen L, Kroczek RA, Daha MR, van Kooten C.

Kidney Int. 2005 Nov;68(5):2091-102.

13.

NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase.

de Haij S, Bakker AC, van der Geest RN, Haegeman G, Vanden Berghe W, Aarbiou J, Daha MR, van Kooten C.

J Am Soc Nephrol. 2005 Jun;16(6):1603-11. Epub 2005 Apr 20.

14.

Human renal epithelial cells produce the long pentraxin PTX3.

Nauta AJ, de Haij S, Bottazzi B, Mantovani A, Borrias MC, Aten J, Rastaldi MP, Daha MR, van Kooten C, Roos A.

Kidney Int. 2005 Feb;67(2):543-53.

15.

Mechanism of steroid action in renal epithelial cells.

de Haij S, Daha MR, van Kooten C.

Kidney Int. 2004 May;65(5):1577-88. Review.

16.

Steroid responsiveness of renal epithelial cells. Dissociation of transrepression and transactivation.

de Haij S, Adcock IM, Bakker AC, Gobin SJ, Daha MR, van Kooten C.

J Biol Chem. 2003 Feb 14;278(7):5091-8. Epub 2002 Oct 31.

17.

Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids.

de Haij S, Woltman AM, Bakker AC, Daha MR, van Kooten C.

Br J Pharmacol. 2002 Sep;137(2):197-204.

18.

Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells.

Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C.

J Am Soc Nephrol. 2000 Nov;11(11):2044-55.

19.

IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro.

Deckers JG, De Haij S, van der Woude FJ, van der Kooij SW, Daha MR, van Kooten C.

J Am Soc Nephrol. 1998 Jul;9(7):1187-93.

20.

A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Veldhuisen B, Saris JJ, de Haij S, Hayashi T, Reynolds DM, Mochizuki T, Elles R, Fossdal R, Bogdanova N, van Dijk MA, Coto E, Ravine D, Nørby S, Verellen-Dumoulin C, Breuning MH, Somlo S, Peters DJ.

Am J Hum Genet. 1997 Sep;61(3):547-55.

Supplemental Content

Loading ...
Support Center